NCT06157918View on ClinicalTrials.gov

Relative Bioavailability and Food Effect of SYHA1813 Oral Solution in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

December 20, 2023

Primary Completion Date

January 26, 2024

Study Completion Date

January 26, 2024

Conditions
Healthy Participants
Interventions
DRUG

SYHA1813 oral solution (2.0g:25mg)

SYHA1813 oral solution, 25mg, oral

DRUG

SYHA1813 oral solution (20ml:200mg)

SYHA1813 oral solution, 25mg, oral

Trial Locations (1)

Unknown

Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Shanghai

All Listed Sponsors
lead

Shanghai Runshi Pharmaceutical Technology Co., Ltd

INDUSTRY

NCT06157918 - Relative Bioavailability and Food Effect of SYHA1813 Oral Solution in Healthy Participants | Biotech Hunter | Biotech Hunter